31st May 2012 14:34
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
| |||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Allergy Therapeutics PLC
| ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | X | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to the notification obligation: iii | SOUTHERN FOX INVESTMENTS LTD. | ||||
4. Full name of shareholder(s) (if different from 3.):iv | CHASE NOMINEES
| ||||
5. Date of the transaction and date on which the threshold is crossed or reached: v | 25th May, 2012 | ||||
6. Date on which issuer notified: |
30th May, 2012
| ||||
7. Threshold(s) that is/are crossed or reached: vi, vii | Over 14%
| ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type of shares
if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
Ord GBP 0.01 | 41,527,247
| 41,527,247
| 58,260,011 | 58,260,011 | 14.32% | |||||||||||
GB00B02LCQ05 | ||||||||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
N/A | N/A | N/A | N/A | N/A | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||||
| Nominal | Delta | ||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
58,260,011 | 14.32% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | SOUTHERN FOX INVESTMENTS LTD. | |
11. Number of voting rights proxy holder will cease to hold: | N/A | |
12. Date on which proxy holder will cease to hold voting rights: | N/A | |
13. Additional information: | ||
14. Contact name: | George O'Carroll | |
15. Contact telephone number: | +353-61-472019 | |
Note: Annex should only be submitted to the FSA not the issuer | |
Annex: Notification of major interests in share | |
A: Identity of the persons or legal entity subject to the notification obligation | |
Full name (including legal form of legal entities)
| SOUTHERN FOX INVESTMENTS LTD. |
Contact address (registered office for legal entities)
| QUEENSGATE HOUSE, SOUTH CHURCH STREET, PO BOX 1234, GRAND CAYMAN KY1-1108, CAYMAN ISLANDS
|
Phone number & email
| 1 (345) 949 9876 |
Other useful information (at least legal representative for legal persons)
| Ogier Law Firm - Legal Representative |
B: Identity of the notifier, if applicable | |
Full name
| George O 'Carroll
|
Contact address
| |
Phone number & email
| +353-61-472019 |
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) | Administration |
C: Additional information | |
For notes on how to complete form TR-1 please see the FSA website. |
Related Shares:
Allergy Thera.